Skip to main content
ConductScienceScienceDex

Adam P Bress

NIH Rank #406
Unclaimed recordClaim profile
  • Top 5% Funded
  • R01 Holder
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11206163Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Public Health
  • Pediatrics

NIH Funding · FY2026

Linked Award Amount
$6.2M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#406
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Adam P Bress. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Adam P Bress as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG096179-02R01
    Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the SPRINT trial
    University of Utah
    $5M
    award amount
  • 1R01AG097580-01R01
    Real-world evidence to clarify risk-benefit of antihypertensive intensification vs. de-escalation and blood pressure thresholds to minimize harms and maximize brain and heart health in older adults
    University of Utah
    $660.5K
    award amount
  • 5T32HD114565-02T32
    Utah Pediatric Clinical Pharmacology Training Program
    University of Utah
    $288.3K
    award amount
  • 5K24AG080168-04K24
    Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring.
    University of Utah
    $198.2K
    award amount

Award organization

Organizations that administered FY2026 awards listing Adam P Bress as a PI.

FY2026 award administered by University of Utah (UT).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Utah
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    $5M Cumulative Funding
  6. 2025
    Entered Top 50% Nationally
    Ranked #816
  7. 2025
    Entered Top 25% Nationally
    Ranked #816
  8. 2025
    Entered Top 10% Nationally
    Ranked #816
  9. 2025
    Entered Top 5% Nationally
    Ranked #816
  10. 2025
    R01 Grant Holder
  11. 2026
    $10M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Adam P Bress.

Jordana B. Cohen
University of Pennsylvania
4
shared awards
Jasmeer P Chhatwal
University of Utah
2
shared awards
Jeremy Joseph Pruzin
University of Utah
2
shared awards
Kevin M Watt
University of Utah
2
shared awards
Jordana B. Cohen
University of Utah
1
shared award

Explore further

Find collaborators for Adam P Bress

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →